| Financial Year |
March 31 2023 |
| Monetary Funds |
5,345,749,562.49 |
| Held-for-trading Financial Assets |
1,408,772,987.66 |
| Notes Receivable |
228,480,822.38 |
| Accounts Receivable |
3,083,411,893.74 |
| Advances to Suppliers |
763,284,820.30 |
| Other Receivables |
845,162,547.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,042,502,413.74 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
557,355,578.62 |
| Other Current Assets |
263,451,532.75 |
| Total Current Assets |
18,102,827,093.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
63,636,594.85 |
| Long-term Equity Investment |
996,940,163.70 |
| Investment Properties |
-- |
| Fixed Assetes |
4,055,744,663.75 |
| Under-construction Projects |
327,967,949.40 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,553,730,131.35 |
| R&D expenses |
-- |
| Goodwill |
103,203.85 |
| Long-Term Deferred and Prepaid Expenses |
134,034.69 |
| Deferred Income Tax Assets |
1,656,276,385.35 |
| Other Non-Current Assets |
20,980,243.91 |
| Sub-Total of Non-Current Assets |
11,300,505,599.15 |
| Total Assets |
29,403,332,692.23 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
60,143,870.79 |
| Notes Payable |
2,305,940,106.72 |
| Accounts Payable |
4,298,692,875.68 |
| Accounts Received In Advance |
1,805,811.40 |
| Employee Compensation Payable |
852,130,124.03 |
| Taxes Payable |
100,090,153.41 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,736,170,860.64 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,010,780.88 |
| Other Current Liabilities |
423,612,438.05 |
| Sub-Total of Current Liabilities |
11,769,552,566.20 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,062,738,444.48 |
| Deferred Income Tax Liabilities |
162,029,744.27 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,848,709,499.44 |
| Total Liabilities |
14,618,262,065.64 |
| Paid-In Capital(Or Share Stock) |
2,213,939,223.00 |
| Capital Surplus |
1,494,452,186.09 |
| Surplus Reserve |
3,038,155,711.33 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
7,587,166,522.37 |
| Minority Stockholder's Interest |
128,979,478.15 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
14,656,091,148.44 |
| Owner's Equity（Stockholder's Equity） |
14,785,070,626.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
29,403,332,692.23 |
